Showing results (2331-2340 of 2,355) with videos related to
Sort By:
Pageof 236
Nature Chemical Biology|February 25, 2022
Deubiquitinase-targeting chimeras for targeted protein stabilizationNathaniel J Henning, Lydia Boike, Jessica N Spradlin, et al.Nature Communications|January 17, 2020
Intratumoral heterogeneity and clonal evolution in liver cancerBojan Losic, Amanda J Craig, Carlos Villacorta-Martin, et al.Journal of Global Health|January 8, 2021
Improving primary health care delivery in Bihar, India: Learning from piloting and statewide scale-up of AnanyaGary L Darmstadt, Kevin T Pepper, Victoria C Ward, et al.The Science of the Total Environment|March 23, 2022
Direct observations of CO2 emission reductions due to COVID-19 lockdown across European urban districtsGiacomo Nicolini, Gabriele Antoniella, Federico Carotenuto, et al.The Lancet. Respiratory Medicine|November 28, 2025
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) modelHnin W W Aung, Kristina Vermeersch, Hamish J C McAuley, et al.Gynecologic Oncology|November 7, 2020
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancersSandra Russo, Joan L Walker, Jay W Carlson, et al.JCO Precision Oncology|June 29, 2023
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER CollaborationChristine N Bailey, Brian J Martin, Valentina I Petkov, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.Pageof 236